Clinical Rheumatology

, Volume 21, Issue 4, pp 343–344 | Cite as

Cocaine and Arsenic-Induced Raynaud’s Phenomenon

  • B. Noël


  1. 1.
    Balbir-Gurman A, Braun-Moscovici Y, Nahir AM. Cocaineinduced Raynaud’s phenomenon and ischaemic finger necrosis. Clin Rheumatol 2001;20:376–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Kumar PD, Smith HR . Cocaine-related vasculitis causing upperlimb peripheral vascular disease. Ann Intern Med 2000;;133:923–4.PubMedCrossRefGoogle Scholar
  3. 3.
    Marder VJ, Mellinghoff IK. Cocaine and Buerger disease: is there a pathogenetic association? Arch Intern Med 2000; 160:2057–60.PubMedCrossRefGoogle Scholar
  4. 4.
    Schneider F, Abdoucheli-Baudot N, Tassart M, Boudghene F, Gouny P. Cannabis and tobacco: cofactors favoring juvenile obliterative arteriopathy. J Mal Vasc 2000;25:388–9.PubMedGoogle Scholar
  5. 5.
    Disdier P, Granel B, Serratrice Jet al . Cannabis arteritis revisited – ten new case reports. Angiology 2001;52:1–5.PubMedGoogle Scholar
  6. 6.
    Noel B. Buerger disease or arsenic intoxication? Arch Intern Med 2001;161:1016.PubMedCrossRefGoogle Scholar
  7. 7.
    Grobe VJ. Peripheral circulatory disorders and acrocyanosis in arsenic exposed Moselle wine-growers. Berufsdermatosen 1976;24:78–84.PubMedGoogle Scholar
  8. 8.
    Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med 2000;343:864–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Tseng CH, Chong CK, Chen CJ, Tai TY. Dose–response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 1996;120:125–33.PubMedCrossRefGoogle Scholar
  10. 10.
    Lagerkvist BE, Linderholm H, Nordberg GF. Arsenic and Raynaud’s phenomenon. Vasospastic tendency and excretion of arsenic in smelter workers before and after the summer vacation. Int Arch Occup Environ Health 1988;60:361–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Hill GL, Moeliono J, Tumewu F et al. The Buerger syndrome in Java. A description of the clinical syndrome and some aspects of its aetiology. Br J Surg 1973;60:606–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Rahman M, Chowdhuryo AS, Fukui T et al. Association of thromboangiitis obliterans with cigarette and bidi smoking in Bangladesh: a case–control study. Int J Epidemiol 2000;29:266–70.PubMedCrossRefGoogle Scholar
  13. 13.
    Narang AP, Greval RS, Goyal SC. Arsenic adulteration in Indian tobacco. Indian J Med Sci 1995;49:55–7.PubMedGoogle Scholar
  14. 14.
    Kalant H. Opium revisited: a brief review of its nature,composition, non-medical use and relative risks. Addiction 1997;92:267–77.PubMedGoogle Scholar
  15. 15.
    Lombard J, Levin IH, Weiner WJ. Arsenic intoxication in a cocaine abuser. N Engl J Med 1989;320:869.PubMedGoogle Scholar
  16. 16.
    Pace LW, Turnquist SE, Casteel SW, Johnson PJ, Frankeny RL. Acute arsenic toxicosis in five horses. Vet Pathol 1997;34:160–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Labadie H, Stoessel P, Callard P, Beaugrand M. Hepatic venoocclusive disease and perisinusoidal fibrosis secondary to arsenic poisioning. Gastroenterology 1990;99:1140–3.PubMedGoogle Scholar
  18. 18.
    Chiou HY, Huang WI, Su CL, Chang SF, Hsu YH, Chen CJ. Dose–response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 1997; 28:1717–23.PubMedCrossRefGoogle Scholar
  19. 19.
    Smith KR, Klei LR, Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001;280:442–9.Google Scholar
  20. 20.
    Roboz GJ, Dias S, Lam G et al. Arsenic trioxide induces doseand time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 2000;96:1525–30.PubMedGoogle Scholar
  21. 21.
    Kumar SV, Bhattacharya S. In vitro toxicity of mercury, cadmium, and arsenic to platelet aggregation: influence of adenylate cyclase and phosphodiesterase activity. In Vitr Mol Toxicol 2000;13:137–44.PubMedCrossRefGoogle Scholar
  22. 22.
    Novick SC, Warrell RP Jr. Arsenicals in hematologic cancers. Semin Oncol 2000;27:495–501.PubMedGoogle Scholar
  23. 23.
    Griffin RJ, Lee SH, Rood KL et al. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors. Neoplasia 2000;2:555–60.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Clinical Rheumatology 2002

Authors and Affiliations

  • B. Noël
    • 1
  1. 1.Department of Dermatology,Centre Hospitalier Universitaire Vaudois, LausanneSwitzerland

Personalised recommendations